Senseonics Holdings, Inc. (SENS)
NASDAQ: SENS · Real-Time Price · USD
5.72
+0.33 (6.12%)
At close: Jun 26, 2026, 4:00 PM EDT
5.75
+0.03 (0.52%)
After-hours: Jun 26, 2026, 7:57 PM EDT

Company Description

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.

Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management.

The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners.

Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Senseonics Holdings, Inc.
Senseonics Holdings logo
Country United States
Founded 1996
Industry Medical Devices
Sector Healthcare
Employees 130
CEO Timothy Goodnow

Contact Details

Address:
20451 Seneca Meadows Parkway
Germantown, Maryland 20876-7005
United States
Phone 301 515 7260
Website senseonics.com

Stock Details

Ticker Symbol SENS
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001616543
CUSIP Number 81727U303
ISIN Number US81727U3032
Employer ID 47-1210911
SIC Code 3823

Key Executives

Name Position
Dr. Timothy T. Goodnow Ph.D. President, Chief Executive Officer and Director
Frederick T. Sullivan CPA Chief Financial Officer, Secretary and Treasurer
Dr. Mukul Jain Ph.D. Chief Operating Officer
Dr. Francine Ratner Kaufman M.D. Chief Medical Officer and Director
Brian B. Hansen Chief Commercial Officer and Director
Kenneth L. Horton J.D. General Counsel and Corporate Development Advisor

Latest SEC Filings

Date Type Title
Jun 8, 2026 8-K Current Report
Jun 1, 2026 SD Form - SD
May 20, 2026 S-8 Securities to be offered to employees in employee benefit plans
May 20, 2026 8-K Current Report
May 7, 2026 10-Q Quarterly Report
May 7, 2026 8-K Current Report
May 4, 2026 8-K Current Report
May 1, 2026 424B5 Filing
May 1, 2026 8-K Current Report
Apr 30, 2026 424B5 Filing